Most recently, it has been determined that conolidine and the above derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to your big selection of endogenous opioids. As opposed to most opioid receptors, this receptor functions to be a scavenger and would not act